Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 12, 2016EMBO Molecular MedicineOpen Access

IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment

View Full Paper
Ask AI
Bookmark
Share

Authors

SDSophia DavidsonThe University of MelbourneTMTeresa M McCabeThe Francis Crick InstituteSCStefania CrottaThe Francis Crick Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Davidson et al. (2016) studied this question.

synapsesocial.com/papers/6a0fd2ed2badbc352afec746https://doi.org/10.15252/emmm.201606413
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in California2009 · 1,026 citations
  2. 2Oromucosal Interferon Therapy: Marked Antiviral and Antitumor Activity1999 · 53 citations
  3. 3Mx1 Gene Protects Mice Against the Highly Lethal Human H5N1 Influenza Virus2007 · 52 citations
  4. 4Disease-Promoting Effects of Type I Interferons in Viral, Bacterial, and Coinfections2015 · 201 citations
  5. 5Interferon-λ Contributes to Innate Immunity of Mice against Influenza A Virus but Not against Hepatotropic Viruses2008 · 329 citations